Anindita Chakrabarty

Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase

Joan T. Garrett, Maria G. Olivares, Cammie Rinehart et al. · Proceedings of the National Academy of Sciences · 2011 · 471 citations · Full text

Medicine, Oncology, Pharmacology +16

Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors

Anindita Chakrabarty, Violeta Sánchez, María G. Kuba et al. · Proceedings of the National Academy of Sciences · 2011 · 345 citations

Medicine, Oncology, Pharmacology +17

MicroRNA regulation of cyclooxygenase-2 during embryo implantation

Anindita Chakrabarty, Susanne Tranguch, Takiko Daikoku et al. · Proceedings of the National Academy of Sciences · 2007 · 267 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Bhuvanesh Dave, Ilenia Migliaccio, Maya Gutierrez et al. · Journal of Clinical Oncology · 2010 · 256 citations

Medicine, Oncology, Pharmacology +17

Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Ritwik Ghosh, Archana Narasanna, Shizhen Emily Wang et al. · Cancer Research · 2011 · 224 citations · Full text

Medicine, Oncology, Pharmacology +17